We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Decries Brand Generics, But Plans More Patent Deals
GPhA Decries Brand Generics, But Plans More Patent Deals
May 2, 2006
As a group, nearly all members of the Generic Pharmaceutical Association (GPhA) agree that authorized generics threaten the generic drug industry, but individually many members say they plan to continue entering into such agreements, one expert said at a recent event on Capitol Hill.